Amphotericin B Suspension in Refractory Chronic Sinusitis

Summary

The primary objective of the study is to evaluate the safety and efficacy of Amphotericin B suspension versus placebo in the complete resolution of key chronic sinusitis symptoms during 16 weeks of treatment in patients with refractory, postsurgical CS.

Timeline

Start

2006-12

Primary completion

—

Completion

2007-10

Drugs

Indications